[Dementia in Parkinson's disease]
- PMID: 17925819
[Dementia in Parkinson's disease]
Abstract
Background: Parkinson's disease has traditionally been considered as a pure motor condition; characterized by tremor, rigidity, bradykinesia and slow postural reflexes. The concomitant presence of neuropsychiatric symptoms, including dementia, has been increasingly recognized during the last decade.
Material and methods: Literature on epidemiology, neuropathology and clinical characteristics of dementia in Parkinson's disease was retrieved from PubMed.
Results and interpretation: Dementia in Parkinson's disease is more common than previously assumed. According to cross-sectional studies, up to 30% of the Parkinson patients have dementia and almost all patients with Parkinson' disease develop dementia over time. Dementia is associated with higher mortality, an increased risk of institutionalisation and increased caregiver distress. Reduced visuospatial and executive functions, severe motor symptoms and high age are risk factors for development of dementia. REM sleeping disorders, psychotic symptoms and depression are frequent comorbid conditions. Dementia in Parkinson's disease correlates with increased Lewy body pathology and reduced levels of neurotransmitters (especially acetylcholine) in neocortical and limbic structures of the brain. Treatment with acetylcholine esterase inhibitors has been shown to have moderate symptomatic effect.
Comment in
-
[Rivastigmine against dementia in Parkinson disease?].Tidsskr Nor Laegeforen. 2007 Nov 15;127(22):2973; author reply 2973-4. Tidsskr Nor Laegeforen. 2007. PMID: 18026256 Norwegian. No abstract available.
Similar articles
-
[Neuropsychiatric and cognitive symptoms in Parkinson disease].Tidsskr Nor Laegeforen. 2008 Sep 25;128(18):2072-6. Tidsskr Nor Laegeforen. 2008. PMID: 18846124 Review. Norwegian.
-
A review of studies describing the use of acetyl cholinesterase inhibitors in Parkinson's disease dementia.Acta Psychiatr Scand. 2005 Jun;111(6):403-9. doi: 10.1111/j.1600-0447.2005.00516.x. Acta Psychiatr Scand. 2005. PMID: 15877706 Review.
-
Rivastigmine in Parkinson's disease dementia.Expert Opin Drug Metab Toxicol. 2009 Aug;5(8):941-55. doi: 10.1517/17425250903105420. Expert Opin Drug Metab Toxicol. 2009. PMID: 19619073 Review.
-
[Cognitive and neuropsychiatric disorders in Parkinson's disease].Rev Neurol. 2010 Feb 8;50 Suppl 2:S33-9. Rev Neurol. 2010. PMID: 20205140 Review. Spanish.
-
The epidemiology of dementia associated with Parkinson disease.J Neurol Sci. 2010 Feb 15;289(1-2):18-22. doi: 10.1016/j.jns.2009.08.034. Epub 2009 Sep 4. J Neurol Sci. 2010. PMID: 19733364 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical